Randomization
Individuals will be randomized and allocated at a 1:1 ratio to the two groups (single-drug and combination with oxaliplatin) using a permuted block design with a random block size of 4, 6, and 8. (1–3).A randomization list will be generated electronically using appropriate software immediately after being considered eligible.